We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Farrer Park Hospital announced today the availability of Lutetium-177 Prostate Specific Membrane Antigen Therapy, a treatment for advanced prostate cancer.